Rheumatology Network

Is There Hope for Clinical Trials in Rheumatology?

A Canadian rheumatology trials consortium has closed its doors, leaving behind a manifesto of problems and suggested solutions. Add your thoughts to the lively commentary here ...

Recent Content

A new online journal club, RheumJC, launches with two live chats on Twitter on January 29. It's the first journal club ever in rheumatology, an opportunity for rheumatologists worldwide to discuss important published research.

amyopathic dermatomyositis

Pulmonary embolism and deep vein thrombosis developed in a 40-year-old man with amyopathic dermatomyositis. D-dimer levels were a red flag.

The US Food and Drug Administration (FDA) has approved the interleukin 17A inhibitor secukinumab (Cosentyx) for adults with moderate to severe plaque psoriasis.  

The FDA has decided will not regulate health apps designed to collect disease information. They're not ready to be useful for rheumatology. Nonetheless, your patients are undoubtedly using them.

A recent study confirms an increased risk for type 2 diabetes among gout patients. Quiz yourself here on related comorbidities in gout.

IgG4 levels were low in this study for only systemic sclerosis and Sjögren's. But other patterns suggested aberrant immune regulation.

By clicking Accept, you agree to become a member of the UBM Medica Community.